Medicine and Dentistry
Rheumatoid Arthritis
80%
Patient
62%
Combination Therapy
31%
Spontaneous Remission
24%
Severe Acute Respiratory Syndrome Coronavirus 2
24%
Synovial Membrane
24%
Diseases
19%
Therapeutic Procedure
18%
Cells
16%
Serositis
15%
Psoriatic Arthritis
14%
B Cell
12%
Biological Product
12%
Infection
12%
Biological Marker
11%
Synovitis
11%
Arthritis
11%
Inflammatory Bowel Disease
10%
Scleroderma
9%
Systemic Lupus Erythematosus
9%
COVID-19
9%
CTLA-4
9%
Bronchoalveolar Lavage Fluid
8%
Symptom
8%
Inpatient
8%
Interstitial Lung Disease
8%
Rituximab
8%
Rheumatoid Factor
7%
Analysis
7%
Joint
7%
Autoimmunity
6%
Chlordane
6%
Assessment
6%
Belimumab
6%
Interleukin-6
5%
Fatigue
5%
Myeloid Cell
5%
CD20
5%
Blood
5%
Autoantibody
5%
Immunotherapy
5%
Disease Activity
5%
Bullous Pemphigoid
5%
Pathogenesis
5%
Predictor
5%
Immunology and Microbiology
Inflammatory Arthritis
100%
Cells
26%
Inflammation
23%
Tissues
20%
Psoriatic Arthritis
20%
Biological Product
14%
Methotrexate
13%
Autoantibodies
13%
B Cell
12%
Macrophage
11%
Systemic Lupus Erythematosus
9%
CTLA-4
9%
Synovial Fluid
9%
Immunohistochemistry
9%
Joint
8%
Inflammatory Bowel Disease
8%
Rituximab
8%
Synovitis
7%
Infectious Agent
7%
Rheumatoid Factor
7%
Tumor Necrosis Factor
6%
Fibroblast
6%
Belimumab
6%
Myeloid
5%
Electric Potential
5%
HLA DRB1 Antigen
5%
Bullous Pemphigoid
5%
Inflammatory Disorder
5%
Intravenous Immunoglobulin
5%
Interleukin 6
5%
Autoimmune Disease
5%
Biochemistry, Genetics and Molecular Biology
T Cell
15%
CTLA-4
6%
Association
6%
Fibroblast
5%
Collagen
5%
MicroRNA
5%
HLA-DRB1
5%
